Last update:

Medical economics news

Health

New York City's medical specialist advantage may be an illusion

New York City offers nearly every type of medical specialist but provides fewer specialty health care providers per capita than smaller cities, according to a new study that challenges conventional assumptions about urban ...

Medical economics

Balancing the promise of health AI with its carbon costs

The health care industry is increasingly relying on artificial intelligence—in responding to patient queries, for example—and a new Cornell study shows how decision-makers can use real-world data to build sustainability ...

Addiction

How primary care clinics can help curb the opioid epidemic

The U.S. is in the midst of an opioid epidemic; overdose deaths from synthetic opioids such as fentanyl have increased more than 100-fold since 1999. Medications like buprenorphine, methadone and naltrexone can all help treat ...

Health

Can smarter marketing help 'make America healthy again?'

Not all products are equally beneficial for everyone. Some are double-edged swords—used appropriately, they can be lifesavers; but used in the wrong hands or the wrong way, there can be significant risks involved.

Medical economics

A call to action ahead of Medicaid work requirements

With just over a year to go until low-income people covered by Medicaid expansion in 40 states must start verifying they're working, or are exempt from work requirements, a University of Michigan health care researcher says ...

Medical economics

Curbing the CNA workforce shortage

As the American population ages, the nation faces a crisis in its long-term care system—a shortage of certified nursing assistants.

Medical economics

Subspecialization in oncology increasingly utilized

Subspecialization in oncology is increasing, but varies widely across cancer types and regions, according to a study published online Aug. 12 in the Annals of Internal Medicine.

Medical economics

Vinay Prasad returns to FDA after being ousted

The U.S. Food and Drug Administration (FDA)'s top vaccine regulator is returning to his post less than two weeks after the White House had him ousted.

Medical economics

Work requirements and red tape ahead for millions on Medicaid

Now that the Republicans' big tax-and-spending bill has become law, new bureaucratic hurdles have emerged for millions of Americans who rely on Medicaid for health coverage. A provision in the new law dictates that, in most ...